CDC issues recommendation for Truvada

Share this article:

The CDC issued a recommendation that Americans at risk for AIDS take Gilead's Truvada, a daily pill that has demonstrated it can prevent the infection.

The New York Times conjectures that if this advice is followed, this could signal a shift in AIDS prevention, from condom usage to Truvada and “would mean a 50-fold increase in the number of prescriptions” for the drug.

It also suggests that CDC's statement may have been due to a recent CDC survey in November that showed  condom use is going down, with a 20% rise from 2005 to 2011 in gay men reporting unprotected sex.

This isn't the first time that the NYT has written about the drug's acceptance either. In December of 2013, the paper offered readers an explanation for the drug's low uptake among the gay community.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.